Bonvanel Injection (Ibandronic Acid Sodium Hydrate)
Ibandronate Sodium Monohydrate 3.375mg
Injections · Prescription medication
iWorld Pharmaceutical Co., Ltd.
MFDS item code 201900324 · Notified 2019.01.22 · Insurance code 669605231
Treatment of osteoporosis in postmenopausal women
This medication is used to treat osteoporosis occurring in women after menopause. Women after menopause may have lower bone density due to decreased estrogen levels, which can result in an increased risk of fractures. This drug helps maintain bone health and improve bone density, thereby reducing the risk of fractures. Regular use can prevent the progression of osteoporosis and increase bone strength. Thus, it is effectively used for the management of postmenopausal osteoporosis.
Administer 3mg by intravenous injection over 15 - 30 seconds once every 3 months. Patients should take calcium and vitamin D supplements. If a dose is missed on the scheduled dosing date, administer the injection as soon as possible, then continue regular dosing at 3-month intervals from that date. Patients with hepatic impairment No dose adjustment is required. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment with serum creatinine of 200 µmol/L(2.3mg/dL) or less or creatinine clearance of 30ml/min or more. Administration of this medicine is not recommended in patients with serum creatinine greater than 200 µmol/L(2.3mg/dL) or creatinine clearance less than 30ml/min because clinical experience is insufficient. Older adults No dose adjustment is required.
Efficacy and safety have not been studied in children 18 years of age or younger.
This medication must be administered solely as an intravenous injection, and extreme caution is required as injection into the artery or near the vein can cause tissue damage. It should not be used in patients with allergies to this drug or its components, or in untreated hypocalcemia patients. The use of this drug may cause gastrointestinal-related symptoms such as gastritis, diarrhea, abdominal pain, dyspepsia, nausea, and constipation, as well as symptoms like musculoskeletal pain, arthralgia, and myalgia. Additionally, symptoms similar to influenza such as fever, chills, fatigue, arthralgia, and myalgia may temporarily occur; these symptoms are usually mild and resolve naturally within a short period. Long-term use of this medication can rarely lead to serious side effects such as osteonecrosis of the jaw or bones around the ear, so it is important to thoroughly check oral health before dental treatment. Similar side effects reported include eye inflammation or severe allergic reactions, skin rashes, etc., and if such symptoms occur, immediate medical attention should be sought. This medication can temporarily lower serum calcium levels, so it is necessary to check for hypocalcemia or bone metabolic disorders before administration and ensure adequate intake of calcium and vitamin D. In patients with kidney issues or those on other medications, regular monitoring during treatment is required. The safety of this drug in pregnant or breastfeeding women has not been established, so it is advisable not to use it. In cases of overdose, careful monitoring is needed as it may affect kidney and liver function, and calcium, phosphate, or magnesium supplementation may be necessary. This drug should not be mixed with calcium-containing solutions or other intravenous medications, and used syringes and needles should not be reused but disposed of safely. Finally, the effects of this medication on driving or operating machinery are unknown, so caution is advised.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container at room temperature between 1 degrees and 30 degrees Celsius. Storing it this way helps maintain the drug's efficacy and prevents deterioration.
A colorless and transparent solution in a colorless and transparent glass prefilled syringe with a single-use syringe needle attached.
3ml x 1 vial
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ibandronate Sodium Monohydrate 3.375mg
Injections · Prescription medication
iWorld Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.
Ibandronate Sodium Monohydrate 3.375mg
Solution · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Chodang Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.